Provider review
Levity review
Prints "billed and shipped approximately every four weeks" on every product.
Thirteen charges a year rather than twelve — disclosed rather than discovered.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Levity
From $179/mo, billed approximately every four weeks
FDA warning letter · Levity · February 2026 · addressed to Levity Inc. dba Levity. Details in our review.
- Vs median
- $10/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The disclosure is the story. A four-week shipping and billing cycle is common in this category and almost always unstated; you discover it when a thirteenth charge appears in a year you had budgeted twelve for. Levity prints it on every product, in the same sentence as the price, using the word approximately rather than implying precision it does not have. That single habit makes the whole catalog comparable in a way most of this market is not, provided you do the conversion — thirteen cycles against twelve months is roughly eight percent, and it compounds over a year. The branded pricing needs a second look for a different reason. The branded products are all offered at four-figure monthly cash prices, and those sit well above what the same products cost through the manufacturers' own direct channels. If you want a branded GLP-1 specifically, this is unlikely to be the cheapest route to it, and the page does not present a comparison. The compounded treatment line is where the competitive figure is, and like everything else here it carries no milligram, so what the money buys in drug is unstated.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the billing cycle stated rather than discovered in month thirteen
- You want the introductory discount and the standing rate shown separately
- You want branded and compounded routes from one provider, cancellable at any time
Look elsewhere if
- You are budgeting twelve payments a year. This bills thirteen
- You want a branded product cheaply. These sit above manufacturer-channel prices
- You want a dose behind the figure. None is published
What it actually costs
Price as published
★★ The cadence is disclosed on every single product, in the seller's own words: "billed & shipped approx. every 4 weeks" appears against the treatment line and against each branded product · that is the honest form of a cycle several sellers here run silently, and it means thirteen charges a year rather than twelve — worth converting before comparing against a calendar-month rate · the treatment-and-support line runs from $179/mo, shown struck through with a $50 first-month code · branded products are sold at cash prices on the same four-week cadence: Mounjaro at $1,299/mo, Ozempic at $1,199/mo and Wegovy at $1,599/mo, each also struck through with the same introductory discount · those branded figures are far above the manufacturer-channel prices available elsewhere, so the branded route here is unlikely to be the cheapest way to those products · cancellation is stated as available at any time · no dose is published behind any figure
- Vs median
- $10/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★★ The four-week billing and shipping cycle is disclosed on EVERY product, in the seller's own words and in the same sentence as the price — the honest form of a cadence several rows here run silently. That single habit makes the catalog comparable, provided a reader converts: thirteen cycles against twelve months is roughly eight percent a year. The branded products are sold at four-figure monthly cash prices well above manufacturer-channel alternatives, so the branded route here is unlikely to be the cheapest way to those drugs and the page draws no comparison. No dose published and no low-dose product offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The four-week billing and shipping cycle is stated on every product.
- The introductory discount and the standing rate are shown as separate figures.
- Branded and compounded routes are both offered, with cancellation stated as available.
Pharmacy, labs and oversight
Levity does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Levity publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Levity in February 2026. It is addressed to Levity Inc. dba Levity — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Levity is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
The disclosure is the story. A four-week shipping and billing cycle is common in this category and almost always unstated; a reader discovers it when a thirteenth charge appears in a year they had budgeted twelve for. Levity prints it on every product, in the same sentence as the price, using the word approximately rather than implying precision it does not have. That single habit makes the whole catalog comparable in a way most of this page is not, provided a reader does the conversion — thirteen cycles against twelve months is roughly eight percent, and it compounds over a year. The branded pricing needs a second look for a different reason. Mounjaro, Ozempic and Wegovy are all offered at four-figure monthly cash prices, and those sit well above what the same products cost through the manufacturers' own direct channels. For a reader who wants a branded GLP-1 specifically, this is unlikely to be the cheapest route to it, and the page does not present a comparison. The compounded treatment line is where the competitive figure is, and like everything else here it carries no milligram, so what the money buys in drug is unstated.
The honest cons
Four weeks means thirteen charges a year, not twelve.
- The branded prices sit well above manufacturer-channel alternatives.
- No dose is published behind any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Levity is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#289 of 373
Ordered with the companies that pay us first, and Levity is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Is compounded GLP-1 safe?
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.